Free Trial

Kiniksa Pharmaceuticals International (KNSA) Short Interest Ratio & Short Volume

Kiniksa Pharmaceuticals International logo
$56.85 -1.38 (-2.37%)
Closing price 03:59 PM Eastern
Extended Trading
$56.91 +0.06 (+0.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kiniksa Pharmaceuticals International Short Interest Overview

As of April 15, 2026, Kiniksa Pharmaceuticals International (KNSA) had a short interest of 4.09 million shares sold short, representing 11.50% of the public float. This marks a 0.08% increase in short interest since the prior report. The short interest ratio (days to cover) is 7.2, meaning it would take 7.2 days of the average trading volume of 709,234 shares to cover all short positions.

Current Short Interest
4,093,547 shares
Previous Short Interest
4,090,136 shares
Change Vs. Previous Month
0.08%
Dollar Volume Sold Short
$187.85 million
Short Interest Ratio
7.2 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
76,540,000 shares
Short Percent of Float
11.50%
Today's Trading Volume
452,371 shares
Average Trading Volume
709,234 shares
Today's Volume Vs. Average
64%
Short Selling Kiniksa Pharmaceuticals International?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Kiniksa Pharmaceuticals International and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

KNSA Short Interest Over Time

KNSA Days to Cover Over Time

KNSA Percentage of Float Shorted Over Time

Kiniksa Pharmaceuticals International Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20264,093,547 shares $187.85 million +0.1%11.5%7.22 $45.89
3/31/20264,090,136 shares $196.94 million +8.6%11.5%6.79 $48.15
3/13/20263,767,914 shares $172.50 million +11.3%10.6%5.1 $45.78
2/27/20263,384,065 shares $150.56 million +10.7%9.5%5.5 $44.49
2/13/20263,056,374 shares $138.67 million -0.3%8.7%7.86 $45.37
1/30/20263,064,527 shares $134.59 million -8.8%8.7%4.21 $43.92
1/15/20263,359,576 shares $127.40 million -5.9%9.5%4.61 $37.92
12/31/20253,570,712 shares $147.29 million +15.0%10.1%9.17 $41.25
12/15/20253,103,773 shares $128.96 million +10.8%8.8%8.09 $41.55
11/28/20252,801,537 shares $119.04 million -2.9%7.9%7.94 $42.49
11/14/20252,886,194 shares $116.37 million +2.1%8.2%8.3 $40.32
10/31/20252,827,544 shares $104.65 million +10.5%8.0%4.33 $37.01
10/15/20252,560,000 shares $99.48 million +1.6%7.4%5 $38.86
9/30/20252,520,000 shares $97.85 million +3.7%N/A4.9 $38.83
9/15/20252,430,000 shares $88.84 million -10.3%N/A3.6 $36.56
8/31/20252,710,000 shares $90.76 million +29.7%7.9%3.7 $33.49
8/15/20252,090,000 shares $69.76 million -14.0%N/A2.7 $33.38
7/31/20252,430,000 shares $73.53 million -4.0%7.0%3.1 $30.26
7/15/20252,530,000 shares $71.07 million +22.2%N/A3.3 $28.09
6/30/20252,070,000 shares $57.28 million -12.3%6.1%2.6 $27.67
6/15/20252,360,000 shares $66.79 million -13.2%7.0%3.6 $28.30
5/31/20252,720,000 shares $74.61 million -17.8%8.3%4.4 $27.43
5/15/20253,310,000 shares $85.63 million -0.6%10.1%5.1 $25.87
4/30/20253,330,000 shares $89.81 million +0.3%N/A5.1 $26.97
4/15/20253,320,000 shares $70.45 million +6.1%10.1%5.3 $21.22
3/31/20253,130,000 shares $69.52 million +2.0%9.5%5.1 $22.21
3/15/20253,070,000 shares $69.41 million +2.3%9.4%5.3 $22.61
2/28/20253,000,000 shares $60.84 million +1.4%9.1%5.4 $20.28
2/15/20252,960,000 shares $58.43 million +53.4%9.0%6.4 $19.74
1/31/20251,930,000 shares $37.83 million -8.5%N/A4.4 $19.60
1/15/20252,110,000 shares $39.71 million -37.8%N/A5.4 $18.82
12/31/20243,390,000 shares $67.05 million +4.0%N/A10.1 $19.78
12/15/20243,260,000 shares $65.85 million -18.9%N/A10.5 $20.20
11/30/20244,020,000 shares $88.76 million -2.2%N/A11.2 $22.08
11/15/20244,110,000 shares $87.50 million -2.4%N/A11.4 $21.29
10/31/20244,210,000 shares $95.10 million +5.0%N/A11.4 $22.59
10/15/20244,010,000 shares $108.51 million -2.0%N/A10.6 $27.06
9/30/20244,090,000 shares $102.21 million -11.9%N/A8.7 $24.99
9/15/20244,640,000 shares $117.21 million +2.0%N/A9.2 $25.26
8/31/20244,550,000 shares $121.67 million -3.4%N/A9.8 $26.74
8/15/20244,710,000 shares $123.26 million +4.4%N/A10 $26.17
7/31/20244,510,000 shares $119.97 million +14.5%N/A9.7 $26.60
7/15/20243,940,000 shares $85.14 million -13.6%N/A8.6 $21.61
6/30/20244,560,000 shares $85.14 million -2.2%N/A11.9 $18.67
6/15/20244,660,000 shares $87.47 million +13.1%N/A13.2 $18.77
5/31/20244,120,000 shares $78.32 million +3.3%N/A11.7 $19.01
5/15/20243,990,000 shares $80.20 million +2.1%N/A10.5 $20.10
4/30/20243,910,000 shares $73.20 million +7.4%N/A10.1 $18.72
4/15/20243,640,000 shares $63.48 million +13.4%N/A9.9 $17.44
3/31/20243,210,000 shares $63.33 million +11.9%N/A8.5 $19.73
3/15/20242,870,000 shares $57.37 million +3.2%N/A6.9 $19.99
2/29/20242,780,000 shares $58.77 million +3.0%N/A6.2 $21.14
2/15/20242,700,000 shares $54.46 million -2.2%N/A6.3 $20.17
1/31/20242,760,000 shares $48.66 million +5.8%N/A6.2 $17.63
1/15/20242,610,000 shares $49.25 million -9.1%N/A5.4 $18.87
12/31/20232,870,000 shares $50.34 million -12.5%N/A6.1 $17.54
12/15/20233,280,000 shares $59.01 million -4.4%N/A8 $17.99
11/30/20233,430,000 shares $55.46 million +0.6%N/A9.5 $16.17
11/15/20233,410,000 shares $53.64 million +6.2%N/A10.3 $15.73
10/31/20233,210,000 shares $48.95 million -17.7%N/A9.5 $15.25
10/15/20233,900,000 shares $63.61 million +0.8%N/A8.8 $16.31
9/30/20233,870,000 shares $67.22 million +1.3%N/A8.2 $17.37
9/15/20233,820,000 shares $65.47 million -0.8%N/A8 $17.14
8/31/20233,850,000 shares $66.34 million -1.5%N/A7.5 $17.23
8/15/20233,910,000 shares $64.91 million +13.7%N/A7.3 $16.60
7/31/20233,440,000 shares $64.81 million +30.8%N/A6.4 $18.84
7/15/20232,630,000 shares $38.21 million -1.1%N/A5.3 $14.53
6/30/20232,660,000 shares $37.45 million -2.9%N/A6.6 $14.08
6/15/20232,740,000 shares $44.83 million +3.4%N/A6.7 $16.36
5/31/20232,650,000 shares $36.73 million -4.7%N/A6.3 $13.86
5/15/20232,780,000 shares $39.89 million -11.5%N/A6.5 $14.35
4/30/20233,140,000 shares $33.76 million +8.3%N/A7.5 $10.75
4/15/20232,900,000 shares $32.92 million -3.7%N/A7.6 $11.35
3/31/20233,010,000 shares $32.39 million +19.4%N/A7.7 $10.76
3/15/20232,520,000 shares $28.78 million -7.4%N/A6.7 $11.42
2/28/20232,720,000 shares $34.98 million -0.4%N/A7.6 $12.86
2/15/20232,730,000 shares $36.80 million -0.7%N/A7.9 $13.48
1/31/20232,750,000 shares $39.77 million -4.8%N/A7.5 $14.46
1/15/20232,890,000 shares $42.05 million +2.5%N/A7.7 $14.55
12/30/20222,820,000 shares $42.24 million +38.2%N/A7.3 $14.98
12/15/20222,040,000 shares $32.19 million -22.7%N/A5.3 $15.78
11/30/20222,640,000 shares $44.43 million -5.4%N/A7.5 $16.83
11/15/20222,790,000 shares $43.97 million +2.2%N/A8.1 $15.76
10/31/20222,730,000 shares $31.18 million +3.0%N/A8.2 $11.42
10/15/20222,650,000 shares $35.96 million -8.0%N/A7.8 $13.57
9/30/20222,880,000 shares $36.98 million +18.5%N/A8.2 $12.84
9/15/20222,430,000 shares $25.44 million +7.5%N/A7.8 $10.47
8/31/20222,260,000 shares $26.49 million +15.3%N/A6.9 $11.72
8/15/20221,960,000 shares $24.42 million +1.6%N/A5.9 $12.46
7/31/20221,930,000 shares $19.13 million -18.2%N/A5.7 $9.91
7/15/20222,360,000 shares $26.55 million -2.9%N/A8.3 $11.25
6/30/20222,430,000 shares $23.55 million -4.7%N/A8.9 $9.69
6/15/20222,550,000 shares $21.78 million +2.4%N/A9.2 $8.54
5/31/20222,490,000 shares $19.07 million +1.6%N/A8.1 $7.66
5/15/20222,450,000 shares $20.14 million +7.0%N/A7.7 $8.22
4/30/20222,290,000 shares $21.37 million -0.9%N/A7.3 $9.33
4/15/20222,310,000 shares $25.94 million -10.5%N/A7 $11.23
3/31/20222,580,000 shares $25.65 million -20.9%N/A7.3 $9.94
3/15/20223,260,000 shares $30.97 million -0.6%N/A8.4 $9.50
2/28/20223,280,000 shares $33.59 million +16.7%N/A8.1 $10.24
2/15/20222,810,000 shares $31.95 million +3.3%N/A6.9 $11.37
1/31/20222,720,000 shares $30.55 million +19.3%8.5%6.8 $11.23
1/15/20222,280,000 shares $25.83 million +0.9%N/A5.3 $11.33
12/31/20212,260,000 shares $26.60 million -15.7%N/A5.6 $11.77
12/15/20212,680,000 shares $35.32 million +10.3%N/A7 $13.18
11/30/20212,430,000 shares $28.24 million +12.0%N/A7.2 $11.62
11/15/20212,170,000 shares $28.28 million -33.0%N/A6.5 $13.03
10/29/20213,240,000 shares $33.66 million +1.6%N/A9.1 $10.39
10/15/20213,190,000 shares $36.53 million -11.6%10.2%7.7 $11.45
9/30/20213,610,000 shares $41.12 million -5.0%11.6%8.2 $11.39
9/15/20213,800,000 shares $45.41 million -7.3%12.2%8.3 $11.95
8/31/20214,100,000 shares $51.58 million -12.6%13.2%8.7 $12.58
8/13/20214,690,000 shares $57.41 million -3.9%15.0%9.1 $12.24
7/30/20214,880,000 shares $74.81 million +2.1%15.7%9.9 $15.33
7/15/20214,780,000 shares $64.63 million +2.1%15.4%12.2 $13.52
6/30/20214,680,000 shares $65.19 million +12.0%15.1%11.4 $13.93
6/15/20214,180,000 shares $61.07 million -5.0%13.5%9.4 $14.61
5/28/20214,400,000 shares $59.97 million -5.2%14.2%8.1 $13.63
5/14/20214,640,000 shares $64.17 million +0.7%N/A8.8 $13.83

KNSA Short Interest - Frequently Asked Questions

What is Kiniksa Pharmaceuticals International's current short interest?

Short interest is the volume of Kiniksa Pharmaceuticals International shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 4,093,547 shares of KNSA short. 11.50% of Kiniksa Pharmaceuticals International's shares are currently sold short. Learn More on Kiniksa Pharmaceuticals International's current short interest.

What is a good short interest ratio for Kiniksa Pharmaceuticals International?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KNSA shares currently have a short interest ratio of 7.2. Learn More on Kiniksa Pharmaceuticals International's short interest ratio.

Which institutional investors are shorting Kiniksa Pharmaceuticals International?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kiniksa Pharmaceuticals International: Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Kiniksa Pharmaceuticals International?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.50% of Kiniksa Pharmaceuticals International's floating shares are currently sold short.

Is Kiniksa Pharmaceuticals International's short interest increasing or decreasing?

Kiniksa Pharmaceuticals International saw a increase in short interest in April. As of April 15th, there was short interest totaling 4,093,547 shares, an increase of 0.1% from the previous total of 4,090,136 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Kiniksa Pharmaceuticals International's short interest compare to its competitors?

11.50% of Kiniksa Pharmaceuticals International's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kiniksa Pharmaceuticals International: Regencell Bioscience Holdings Limited (0.17%), Ascendis Pharma A/S (9.77%), BridgeBio Pharma, Inc. (14.30%), Dr. Reddy's Laboratories Ltd (1.62%), Elanco Animal Health Incorporated (4.99%), Axsome Therapeutics, Inc. (6.74%), Arrowhead Pharmaceuticals, Inc. (8.90%), Abivax SA Sponsored ADR (3.23%), Praxis Precision Medicines, Inc. (13.95%), Vaxcyte, Inc. (10.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Kiniksa Pharmaceuticals International stock?

Short selling KNSA is an investing strategy that aims to generate trading profit from Kiniksa Pharmaceuticals International as its price is falling. KNSA shares are trading down $2.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kiniksa Pharmaceuticals International?

A short squeeze for Kiniksa Pharmaceuticals International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KNSA, which in turn drives the price of the stock up even further.

How often is Kiniksa Pharmaceuticals International's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KNSA, twice per month. The most recent reporting period available is April, 15 2026.

What do KNSA's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like KNSA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.




This page (NASDAQ:KNSA) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners